Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hematopoietic Stem Cell Transplantation | 64 | 2024 | 5445 | 4.050 |
Why?
|
Graft vs Host Disease | 38 | 2024 | 2958 | 3.150 |
Why?
|
Epstein-Barr Virus Infections | 9 | 2024 | 570 | 2.330 |
Why?
|
Severe Combined Immunodeficiency | 10 | 2024 | 223 | 1.670 |
Why?
|
Lymphoproliferative Disorders | 5 | 2024 | 524 | 1.540 |
Why?
|
Cytomegalovirus Infections | 6 | 2023 | 820 | 1.530 |
Why?
|
Transplantation Conditioning | 22 | 2024 | 1599 | 1.350 |
Why?
|
Adoptive Transfer | 5 | 2022 | 844 | 1.300 |
Why?
|
Herpesvirus 4, Human | 7 | 2024 | 1041 | 1.210 |
Why?
|
Lymphocyte Depletion | 8 | 2020 | 608 | 1.110 |
Why?
|
T-Lymphocytes | 27 | 2024 | 10183 | 1.100 |
Why?
|
Transplantation, Homologous | 29 | 2023 | 4777 | 0.970 |
Why?
|
Leukemia | 4 | 2023 | 1510 | 0.940 |
Why?
|
Cytomegalovirus | 5 | 2023 | 733 | 0.870 |
Why?
|
Organ Transplantation | 3 | 2024 | 1140 | 0.870 |
Why?
|
Transplants | 1 | 2022 | 209 | 0.700 |
Why?
|
Thymus Gland | 6 | 2004 | 1267 | 0.700 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 3 | 2023 | 1520 | 0.570 |
Why?
|
Lymphoma | 4 | 2024 | 1877 | 0.570 |
Why?
|
Immunotherapy, Adoptive | 7 | 2020 | 1271 | 0.560 |
Why?
|
Peripheral Blood Stem Cell Transplantation | 4 | 2020 | 272 | 0.540 |
Why?
|
Leukemia, Myeloid, Acute | 8 | 2023 | 3524 | 0.540 |
Why?
|
beta-Thalassemia | 4 | 2022 | 225 | 0.520 |
Why?
|
Fanconi Anemia | 4 | 2023 | 319 | 0.490 |
Why?
|
Viremia | 5 | 2023 | 736 | 0.490 |
Why?
|
Antilymphocyte Serum | 6 | 2024 | 492 | 0.450 |
Why?
|
Cord Blood Stem Cell Transplantation | 5 | 2015 | 314 | 0.450 |
Why?
|
Hematologic Neoplasms | 7 | 2023 | 1832 | 0.450 |
Why?
|
T-Lymphocytes, Cytotoxic | 6 | 2021 | 1821 | 0.420 |
Why?
|
Mesenchymal Stem Cell Transplantation | 4 | 2020 | 496 | 0.410 |
Why?
|
Myeloablative Agonists | 6 | 2020 | 218 | 0.390 |
Why?
|
Vidarabine | 5 | 2018 | 345 | 0.350 |
Why?
|
Busulfan | 5 | 2023 | 263 | 0.330 |
Why?
|
Child | 49 | 2024 | 77709 | 0.330 |
Why?
|
Histocompatibility Testing | 6 | 2019 | 741 | 0.330 |
Why?
|
Adenoviridae Infections | 2 | 2020 | 96 | 0.320 |
Why?
|
Virus Diseases | 3 | 2022 | 711 | 0.320 |
Why?
|
CD4-Positive T-Lymphocytes | 5 | 2022 | 4386 | 0.320 |
Why?
|
Antigen-Presenting Cells | 1 | 2011 | 973 | 0.310 |
Why?
|
Myelodysplastic Syndromes | 5 | 2017 | 1352 | 0.300 |
Why?
|
T-Lymphocyte Subsets | 3 | 2004 | 1837 | 0.290 |
Why?
|
Kidney Transplantation | 1 | 2022 | 4251 | 0.290 |
Why?
|
Tissue Donors | 6 | 2024 | 2241 | 0.270 |
Why?
|
Hematopoietic Stem Cells | 5 | 2014 | 3390 | 0.250 |
Why?
|
Chimerism | 3 | 2021 | 158 | 0.250 |
Why?
|
Acute Disease | 9 | 2021 | 7147 | 0.250 |
Why?
|
Cyclophosphamide | 4 | 2023 | 2242 | 0.250 |
Why?
|
Humans | 94 | 2024 | 744366 | 0.250 |
Why?
|
Viral Matrix Proteins | 2 | 2015 | 186 | 0.240 |
Why?
|
Candidiasis, Chronic Mucocutaneous | 1 | 2023 | 19 | 0.230 |
Why?
|
Antigens, Viral | 2 | 2019 | 1035 | 0.230 |
Why?
|
Child, Preschool | 31 | 2023 | 41005 | 0.230 |
Why?
|
Mesenchymal Stem Cells | 3 | 2020 | 1632 | 0.230 |
Why?
|
Interleukin Receptor Common gamma Subunit | 2 | 2018 | 88 | 0.220 |
Why?
|
Janus Kinase 3 | 2 | 2018 | 78 | 0.220 |
Why?
|
Granulomatous Disease, Chronic | 1 | 2023 | 174 | 0.220 |
Why?
|
Integrins | 2 | 2004 | 846 | 0.210 |
Why?
|
Lymphopenia | 1 | 2024 | 285 | 0.200 |
Why?
|
Cell Movement | 4 | 2003 | 5218 | 0.200 |
Why?
|
Hemoglobinopathies | 1 | 2021 | 96 | 0.190 |
Why?
|
Proto-Oncogene Proteins c-ets | 1 | 2022 | 318 | 0.190 |
Why?
|
Agammaglobulinemia | 1 | 2022 | 167 | 0.190 |
Why?
|
Antigens, CD34 | 5 | 2022 | 659 | 0.190 |
Why?
|
Hemoglobinuria, Paroxysmal | 2 | 2011 | 102 | 0.190 |
Why?
|
Globins | 1 | 2022 | 416 | 0.190 |
Why?
|
Opportunistic Infections | 1 | 2023 | 389 | 0.190 |
Why?
|
Leukemia, Promyelocytic, Acute | 1 | 2022 | 236 | 0.180 |
Why?
|
Infant | 22 | 2022 | 35134 | 0.180 |
Why?
|
Retrospective Studies | 27 | 2024 | 77460 | 0.180 |
Why?
|
Disease-Free Survival | 7 | 2020 | 6896 | 0.180 |
Why?
|
Adenylate Kinase | 1 | 2020 | 99 | 0.180 |
Why?
|
Leukopenia | 1 | 2020 | 213 | 0.180 |
Why?
|
Wiskott-Aldrich Syndrome | 1 | 2020 | 131 | 0.180 |
Why?
|
Wiskott-Aldrich Syndrome Protein | 1 | 2020 | 160 | 0.170 |
Why?
|
Cadherins | 1 | 2004 | 907 | 0.170 |
Why?
|
Neoplasm Recurrence, Local | 8 | 2024 | 9240 | 0.170 |
Why?
|
Lentivirus | 1 | 2022 | 503 | 0.170 |
Why?
|
Salvage Therapy | 3 | 2019 | 1275 | 0.160 |
Why?
|
Extracellular Matrix Proteins | 1 | 2002 | 850 | 0.160 |
Why?
|
Bone Marrow Transplantation | 3 | 2018 | 2765 | 0.160 |
Why?
|
Standard of Care | 1 | 2022 | 564 | 0.160 |
Why?
|
Bone Marrow Cells | 2 | 2023 | 2513 | 0.160 |
Why?
|
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2019 | 222 | 0.160 |
Why?
|
Adolescent | 33 | 2023 | 85779 | 0.150 |
Why?
|
Alleles | 3 | 2024 | 6933 | 0.150 |
Why?
|
Introns | 1 | 2020 | 992 | 0.150 |
Why?
|
Antigens, CD19 | 1 | 2019 | 380 | 0.150 |
Why?
|
Young Adult | 24 | 2024 | 56429 | 0.150 |
Why?
|
Survival Rate | 7 | 2020 | 12788 | 0.150 |
Why?
|
Gene Transfer Techniques | 2 | 2014 | 1225 | 0.140 |
Why?
|
Hematologic Diseases | 2 | 2020 | 498 | 0.140 |
Why?
|
Adult | 35 | 2023 | 214052 | 0.140 |
Why?
|
Anemia, Aplastic | 1 | 2018 | 226 | 0.140 |
Why?
|
Phosphoproteins | 2 | 2015 | 2441 | 0.140 |
Why?
|
Male | 45 | 2024 | 350115 | 0.130 |
Why?
|
HLA Antigens | 4 | 2016 | 1382 | 0.130 |
Why?
|
Myeloproliferative Disorders | 1 | 2022 | 606 | 0.130 |
Why?
|
Mycophenolic Acid | 2 | 2015 | 343 | 0.130 |
Why?
|
Genetic Vectors | 3 | 2022 | 3424 | 0.130 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 2 | 2018 | 1378 | 0.130 |
Why?
|
Cytomegalovirus Retinitis | 1 | 2015 | 58 | 0.120 |
Why?
|
CD4 Lymphocyte Count | 1 | 2021 | 2560 | 0.120 |
Why?
|
Survival Analysis | 10 | 2020 | 10252 | 0.120 |
Why?
|
Recurrence | 3 | 2023 | 8340 | 0.120 |
Why?
|
Lymphocyte Transfusion | 1 | 2015 | 236 | 0.120 |
Why?
|
Neonatal Screening | 3 | 2024 | 591 | 0.120 |
Why?
|
Neoplasms | 1 | 2023 | 21696 | 0.120 |
Why?
|
Neoplasm, Residual | 2 | 2019 | 973 | 0.120 |
Why?
|
Down Syndrome | 1 | 2022 | 880 | 0.120 |
Why?
|
Female | 40 | 2024 | 380193 | 0.110 |
Why?
|
Anemia, Sickle Cell | 1 | 2021 | 1020 | 0.110 |
Why?
|
Interleukins | 1 | 2018 | 791 | 0.110 |
Why?
|
Lung Diseases | 1 | 2024 | 1887 | 0.110 |
Why?
|
beta-Globins | 1 | 2014 | 115 | 0.110 |
Why?
|
Infection Control | 1 | 2020 | 965 | 0.110 |
Why?
|
Remission Induction | 2 | 2016 | 2385 | 0.110 |
Why?
|
Skin Diseases | 1 | 2021 | 1066 | 0.110 |
Why?
|
Hematopoietic Stem Cell Mobilization | 1 | 2014 | 227 | 0.110 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2023 | 4479 | 0.110 |
Why?
|
Antiviral Agents | 3 | 2022 | 2987 | 0.110 |
Why?
|
Drug Resistance, Neoplasm | 2 | 2019 | 5172 | 0.110 |
Why?
|
Cell Differentiation | 7 | 2018 | 11486 | 0.100 |
Why?
|
Dyskeratosis Congenita | 1 | 2012 | 72 | 0.100 |
Why?
|
Immunocompromised Host | 1 | 2017 | 847 | 0.100 |
Why?
|
Transplantation Chimera | 2 | 2004 | 613 | 0.100 |
Why?
|
Chickenpox Vaccine | 1 | 2011 | 79 | 0.100 |
Why?
|
Meningococcal Infections | 1 | 2011 | 77 | 0.100 |
Why?
|
Keratinocytes | 1 | 2015 | 799 | 0.100 |
Why?
|
Meningococcal Vaccines | 1 | 2011 | 95 | 0.100 |
Why?
|
Repressor Proteins | 1 | 2022 | 3024 | 0.090 |
Why?
|
Genetic Association Studies | 1 | 2020 | 2703 | 0.090 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2019 | 2540 | 0.090 |
Why?
|
Infant, Newborn | 8 | 2024 | 25628 | 0.090 |
Why?
|
Exanthema | 1 | 2015 | 501 | 0.090 |
Why?
|
Antineoplastic Agents, Alkylating | 1 | 2014 | 627 | 0.090 |
Why?
|
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2014 | 407 | 0.090 |
Why?
|
Herpesvirus 3, Human | 1 | 2011 | 204 | 0.090 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 3 | 2017 | 11525 | 0.090 |
Why?
|
Hodgkin Disease | 1 | 2017 | 1415 | 0.090 |
Why?
|
Clinical Trials, Phase I as Topic | 1 | 2010 | 323 | 0.080 |
Why?
|
Animals, Newborn | 2 | 2004 | 2726 | 0.080 |
Why?
|
Melphalan | 3 | 2017 | 431 | 0.080 |
Why?
|
Lymphocyte Count | 2 | 2022 | 793 | 0.080 |
Why?
|
Prognosis | 5 | 2020 | 29060 | 0.070 |
Why?
|
Radiation Chimera | 2 | 2004 | 223 | 0.070 |
Why?
|
Mice | 8 | 2023 | 81201 | 0.070 |
Why?
|
Gastrointestinal Tract | 1 | 2013 | 814 | 0.070 |
Why?
|
Treatment Outcome | 12 | 2021 | 63107 | 0.070 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2020 | 2988 | 0.070 |
Why?
|
Immunization | 2 | 2011 | 1256 | 0.070 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2013 | 1381 | 0.070 |
Why?
|
Canada | 2 | 2023 | 2065 | 0.070 |
Why?
|
Multicenter Studies as Topic | 1 | 2010 | 1677 | 0.060 |
Why?
|
B-Lymphocytes | 2 | 2018 | 4666 | 0.060 |
Why?
|
Transduction, Genetic | 2 | 2022 | 913 | 0.060 |
Why?
|
Tissue Plasminogen Activator | 1 | 2011 | 1261 | 0.060 |
Why?
|
Animals | 12 | 2023 | 168768 | 0.060 |
Why?
|
Receptors, Cell Surface | 1 | 2014 | 2865 | 0.060 |
Why?
|
Hepatitis B Vaccines | 1 | 2006 | 194 | 0.060 |
Why?
|
Lymphocytes, Null | 1 | 2004 | 13 | 0.060 |
Why?
|
Animals, Congenic | 1 | 2004 | 27 | 0.060 |
Why?
|
Thymus Extracts | 1 | 2004 | 2 | 0.060 |
Why?
|
Receptors, Interleukin-7 | 1 | 2004 | 38 | 0.060 |
Why?
|
Cell Division | 2 | 2004 | 4569 | 0.060 |
Why?
|
Genetic Variation | 1 | 2020 | 6542 | 0.060 |
Why?
|
Cell Adhesion | 2 | 2002 | 3144 | 0.060 |
Why?
|
Adenoviridae | 2 | 2020 | 1101 | 0.060 |
Why?
|
Steroids | 2 | 2020 | 930 | 0.060 |
Why?
|
Viral Load | 3 | 2020 | 3300 | 0.060 |
Why?
|
Specific Pathogen-Free Organisms | 1 | 2004 | 226 | 0.060 |
Why?
|
Membrane Proteins | 1 | 2020 | 7882 | 0.060 |
Why?
|
Neoplasms, Second Primary | 1 | 2011 | 1062 | 0.060 |
Why?
|
Thrombocytopenia | 1 | 2011 | 1178 | 0.060 |
Why?
|
Injections, Intralymphatic | 1 | 2002 | 15 | 0.060 |
Why?
|
Peptides | 1 | 2015 | 4410 | 0.050 |
Why?
|
Stromal Cells | 3 | 2003 | 1355 | 0.050 |
Why?
|
Proportional Hazards Models | 3 | 2023 | 12356 | 0.050 |
Why?
|
Thrombolytic Therapy | 1 | 2011 | 2162 | 0.050 |
Why?
|
STAT1 Transcription Factor | 1 | 2023 | 320 | 0.050 |
Why?
|
Fibrinolytic Agents | 1 | 2011 | 2158 | 0.050 |
Why?
|
Middle Aged | 17 | 2023 | 213390 | 0.050 |
Why?
|
Kaplan-Meier Estimate | 3 | 2021 | 6539 | 0.050 |
Why?
|
Immunodominant Epitopes | 1 | 2022 | 267 | 0.050 |
Why?
|
Luminescent Proteins | 1 | 2004 | 853 | 0.050 |
Why?
|
Immunosuppressive Agents | 3 | 2011 | 4153 | 0.050 |
Why?
|
Pandemics | 1 | 2020 | 8385 | 0.050 |
Why?
|
Adenosine Deaminase | 1 | 2022 | 241 | 0.050 |
Why?
|
North America | 1 | 2024 | 1249 | 0.050 |
Why?
|
Genes, Reporter | 1 | 2004 | 1547 | 0.050 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 1 | 2002 | 707 | 0.040 |
Why?
|
Granulocyte Colony-Stimulating Factor | 1 | 2022 | 648 | 0.040 |
Why?
|
Prospective Studies | 6 | 2023 | 53290 | 0.040 |
Why?
|
Organ Size | 1 | 2004 | 2251 | 0.040 |
Why?
|
Mice, Knockout | 2 | 2004 | 14561 | 0.040 |
Why?
|
Gene Fusion | 1 | 2022 | 371 | 0.040 |
Why?
|
Mice, SCID | 1 | 2004 | 2716 | 0.040 |
Why?
|
Clinical Trials as Topic | 1 | 2014 | 7914 | 0.040 |
Why?
|
Green Fluorescent Proteins | 1 | 2004 | 2088 | 0.040 |
Why?
|
Receptors, CXCR4 | 1 | 2003 | 727 | 0.040 |
Why?
|
Genetic Predisposition to Disease | 1 | 2020 | 17446 | 0.040 |
Why?
|
RNA, Ribosomal, 16S | 1 | 2022 | 954 | 0.040 |
Why?
|
Mice, Inbred C57BL | 4 | 2004 | 21833 | 0.040 |
Why?
|
Antigens, Differentiation, T-Lymphocyte | 1 | 2000 | 906 | 0.040 |
Why?
|
Models, Immunological | 1 | 2000 | 527 | 0.040 |
Why?
|
Antibodies, Monoclonal | 3 | 2023 | 9274 | 0.040 |
Why?
|
Follow-Up Studies | 5 | 2021 | 39052 | 0.040 |
Why?
|
Graft Survival | 3 | 2018 | 3737 | 0.040 |
Why?
|
Aged | 11 | 2023 | 163288 | 0.040 |
Why?
|
Europe | 1 | 2024 | 3338 | 0.040 |
Why?
|
Thiotepa | 1 | 2016 | 66 | 0.040 |
Why?
|
Genotype | 2 | 2023 | 12952 | 0.040 |
Why?
|
Arabinonucleosides | 1 | 2016 | 35 | 0.030 |
Why?
|
Chronic Disease | 1 | 2011 | 9145 | 0.030 |
Why?
|
Adenine Nucleotides | 1 | 2016 | 121 | 0.030 |
Why?
|
Neurotoxicity Syndromes | 1 | 2019 | 290 | 0.030 |
Why?
|
Epitopes | 1 | 2022 | 2571 | 0.030 |
Why?
|
Severity of Illness Index | 3 | 2021 | 15535 | 0.030 |
Why?
|
Microscopy, Confocal | 1 | 2021 | 1970 | 0.030 |
Why?
|
RNA Splicing | 1 | 2020 | 908 | 0.030 |
Why?
|
Blood Banks | 1 | 2016 | 111 | 0.030 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2004 | 3921 | 0.030 |
Why?
|
Antibiotic Prophylaxis | 1 | 2020 | 639 | 0.030 |
Why?
|
Whole-Body Irradiation | 1 | 2016 | 449 | 0.030 |
Why?
|
Blood Transfusion | 1 | 2022 | 1301 | 0.030 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2004 | 2455 | 0.030 |
Why?
|
Mice, Transgenic | 2 | 2004 | 9735 | 0.030 |
Why?
|
Immunotherapy | 1 | 2010 | 4446 | 0.030 |
Why?
|
Flow Cytometry | 2 | 2004 | 5974 | 0.030 |
Why?
|
Exons | 1 | 2020 | 2439 | 0.030 |
Why?
|
Bone Marrow | 2 | 2017 | 2948 | 0.030 |
Why?
|
Immunity, Humoral | 1 | 2018 | 598 | 0.030 |
Why?
|
Age of Onset | 1 | 2020 | 3270 | 0.030 |
Why?
|
Receptors, Tumor Necrosis Factor, Type I | 1 | 2014 | 264 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2017 | 10943 | 0.030 |
Why?
|
Colony-Forming Units Assay | 1 | 2014 | 356 | 0.030 |
Why?
|
Antigens, CD | 1 | 2004 | 4026 | 0.030 |
Why?
|
Disease Susceptibility | 1 | 2020 | 1782 | 0.030 |
Why?
|
Antibodies, Neutralizing | 1 | 2023 | 1978 | 0.030 |
Why?
|
Dermatitis | 1 | 2015 | 199 | 0.030 |
Why?
|
Cell Communication | 1 | 2000 | 1621 | 0.030 |
Why?
|
Homeodomain Proteins | 1 | 2022 | 2418 | 0.030 |
Why?
|
Erythroid Precursor Cells | 1 | 2014 | 218 | 0.030 |
Why?
|
Homeostasis | 2 | 2001 | 3339 | 0.030 |
Why?
|
Transplantation, Autologous | 1 | 2017 | 2124 | 0.030 |
Why?
|
Kinetics | 1 | 2020 | 6476 | 0.030 |
Why?
|
Siblings | 1 | 2017 | 854 | 0.030 |
Why?
|
Incidence | 2 | 2023 | 20952 | 0.030 |
Why?
|
Trans-Activators | 1 | 2022 | 2926 | 0.030 |
Why?
|
Mutation | 3 | 2022 | 29786 | 0.030 |
Why?
|
Calcineurin | 1 | 2013 | 226 | 0.030 |
Why?
|
Budesonide | 1 | 2013 | 154 | 0.030 |
Why?
|
Protein Binding | 1 | 2004 | 9384 | 0.030 |
Why?
|
Tumor Suppressor Proteins | 1 | 2022 | 2850 | 0.030 |
Why?
|
Interleukin-8 | 1 | 2014 | 690 | 0.030 |
Why?
|
DNA Mutational Analysis | 1 | 2020 | 4185 | 0.020 |
Why?
|
Soybean Proteins | 1 | 2011 | 61 | 0.020 |
Why?
|
Plant Lectins | 1 | 2011 | 104 | 0.020 |
Why?
|
Necrosis | 1 | 2015 | 1643 | 0.020 |
Why?
|
Stem Cells | 1 | 2004 | 3567 | 0.020 |
Why?
|
Cytotoxicity, Immunologic | 1 | 2015 | 1369 | 0.020 |
Why?
|
Rabbits | 1 | 2017 | 4894 | 0.020 |
Why?
|
Immunoglobulin Joining Region | 1 | 1990 | 36 | 0.020 |
Why?
|
Postoperative Complications | 1 | 2012 | 15297 | 0.020 |
Why?
|
Antibody Diversity | 1 | 1990 | 74 | 0.020 |
Why?
|
Vaccines, Attenuated | 1 | 2011 | 342 | 0.020 |
Why?
|
Infusions, Intravenous | 1 | 2015 | 2274 | 0.020 |
Why?
|
Hemolysis | 1 | 2011 | 420 | 0.020 |
Why?
|
DNA Nucleotidyltransferases | 1 | 1990 | 193 | 0.020 |
Why?
|
Disease Management | 1 | 2020 | 2460 | 0.020 |
Why?
|
Genes, Immunoglobulin | 1 | 1990 | 291 | 0.020 |
Why?
|
Immunoglobulin Variable Region | 1 | 1990 | 421 | 0.020 |
Why?
|
Cells, Cultured | 1 | 2004 | 19233 | 0.020 |
Why?
|
Graft Rejection | 1 | 2021 | 4397 | 0.020 |
Why?
|
Registries | 1 | 2024 | 8091 | 0.020 |
Why?
|
Cell Proliferation | 1 | 2024 | 10483 | 0.020 |
Why?
|
Leukocyte Reduction Procedures | 1 | 2007 | 15 | 0.020 |
Why?
|
Time Factors | 3 | 2016 | 40075 | 0.020 |
Why?
|
Skin | 1 | 2021 | 4372 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2023 | 13991 | 0.020 |
Why?
|
Lymphocyte Activation | 1 | 2018 | 5524 | 0.020 |
Why?
|
DNA-Binding Proteins | 1 | 2004 | 9647 | 0.020 |
Why?
|
Fatal Outcome | 1 | 2011 | 1851 | 0.020 |
Why?
|
Multivariate Analysis | 1 | 2020 | 12244 | 0.020 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2012 | 2649 | 0.020 |
Why?
|
Antibodies, Bacterial | 1 | 2011 | 1470 | 0.020 |
Why?
|
DNA, Viral | 1 | 2011 | 2227 | 0.020 |
Why?
|
Cohort Studies | 2 | 2020 | 40559 | 0.010 |
Why?
|
Adrenal Cortex Hormones | 1 | 2013 | 1856 | 0.010 |
Why?
|
Tacrolimus | 1 | 2007 | 743 | 0.010 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 1 | 2006 | 693 | 0.010 |
Why?
|
Phenotype | 1 | 2020 | 16367 | 0.010 |
Why?
|
Venous Thrombosis | 1 | 2011 | 1239 | 0.010 |
Why?
|
Anemia | 1 | 2011 | 1503 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2011 | 6171 | 0.010 |
Why?
|
Keratins | 1 | 2003 | 515 | 0.010 |
Why?
|
Neutrophils | 1 | 2014 | 3721 | 0.010 |
Why?
|
United States | 2 | 2021 | 69872 | 0.010 |
Why?
|
Lymphocytes | 1 | 1990 | 2617 | 0.010 |
Why?
|
Chemokines, CXC | 1 | 2003 | 422 | 0.010 |
Why?
|
Enzyme Inhibitors | 1 | 2013 | 3799 | 0.010 |
Why?
|
Chemokine CXCL12 | 1 | 2003 | 465 | 0.010 |
Why?
|
Gene Expression | 1 | 2014 | 7798 | 0.010 |
Why?
|
Signal Transduction | 1 | 2003 | 23404 | 0.010 |
Why?
|
Receptors, Chemokine | 1 | 2003 | 670 | 0.010 |
Why?
|
Methotrexate | 1 | 2007 | 1728 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2015 | 12961 | 0.010 |
Why?
|
Immunoglobulin G | 1 | 2011 | 4561 | 0.010 |
Why?
|
Thrombosis | 1 | 2011 | 2968 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 2007 | 6489 | 0.010 |
Why?
|
Anticoagulants | 1 | 2011 | 4600 | 0.010 |
Why?
|
Risk Assessment | 1 | 2017 | 23336 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2014 | 18034 | 0.010 |
Why?
|
Risk Factors | 2 | 2011 | 72296 | 0.010 |
Why?
|
Hematopoiesis | 1 | 2001 | 2073 | 0.010 |
Why?
|
VDJ Recombinases | 1 | 1990 | 84 | 0.010 |
Why?
|
Pregnancy | 1 | 2011 | 29144 | 0.010 |
Why?
|
Clone Cells | 1 | 1990 | 1692 | 0.000 |
Why?
|
Aged, 80 and over | 1 | 2011 | 57776 | 0.000 |
Why?
|
Gene Rearrangement | 1 | 1990 | 1179 | 0.000 |
Why?
|
Antineoplastic Agents | 1 | 2006 | 13693 | 0.000 |
Why?
|
Cell Line | 1 | 1990 | 16000 | 0.000 |
Why?
|